This article summarized the latest R&D progress of Hydroxycarbamide, the Mechanism of Action for Hydroxycarbamide, and the drug target R&D trends for Hydroxycarbamide.

Merck has reported that the U.S. FDA is conducting a priority analysis on a fresh sBLA petitioning for authorization of KEYTRUDA, Merck’s anti-PD-1 treatment.

This article summarized the latest R&D progress of Gossypol, the Mechanism of Action for Gossypol, and the drug target R&D trends for Gossypol.

Cholinesterase is a class of glycoprotein that is present in the body in various isoenzyme forms. It can be generally divided into true cholinesterase and pseudocholinesterase.

This article summarized the latest R&D progress of Glecaprevir/Pibrentasvir, the Mechanism of Action for Glecaprevir/Pibrentasvir, and the drug target R&D trends for Glecaprevir/Pibrentasvir.

The Menarini Group,together with their fully owned subsidiary Stemline Therapeutics Inc., declared that ORSERDU® (elacestrant) has received authorisation from the European Commission.

This article summarized the latest R&D progress of Ganaxolone, the Mechanism of Action for Ganaxolone, and the drug target R&D trends for Ganaxolone.

Cyclooxygenase, also known as Prostaglandin-endoperoxide Synthase, is a bifunctional enzyme with both cyclooxygenase and peroxidase activity.

This article summarized the latest R&D progress of Gabapentin Enacarbil, the Mechanism of Action for Gabapentin Enacarbil, and the drug target R&D trends for Gabapentin Enacarbil.

The CRC is responsible for drafting product clinical plans, implementing clinical trials, monitoring clinical research quality, tracking research progress, and coordinating clinical trial work.

This article summarized the latest R&D progress of Etravirine, the Mechanism of Action for Etravirine, and the drug target R&D trends for Etravirine.

The CYP2D6 gene encodes the CYP2D6 enzyme, which is a crucial member of the cytochrome P450 system, a crucial enzyme in the metabolism of various drugs.